News | April 01, 2022
Oragnon enters global licencing agreement with Dare Biosciences
An estimated 21 million American women experience BV
An estimated 21 million American women experience BV
Women's health is in fact a direct reflection of the nation's overall health
The supplemental adolescent approval enhances Solosec’s strong position as the first and only single-dose oral prescription antimicrobial agent approved for the treatment of both trichomoniasis and BV
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
PPH is associated with almost 20 per cent of maternal mortality in India
The Visby Medical sexual health click test is the first instrument-free PCR test for the detection of chlamydia, gonorrhoea and trichomonas, with results available within 30 minutes, during the patient visit
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
Intrarosa will not only expand and strengthen our product portfolio into Women's Health in Canada but will cater to satisfy the unmet medical needs.
Subscribe To Our Newsletter & Stay Updated
